News from nuvo research inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 30, 2014, 17:00 ET

Nuvo Research® announces 2014 second quarter results

MISSISSAUGA, ON, July 30, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of...

Jun 17, 2014, 12:30 ET

Nuvo Research to present at Bloom Burton & Co Healthcare Investor Conference

MISSISSAUGA, ON, June 17, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI) a specialty pharmaceutical company with a diverse portfolio of...

Jun 11, 2014, 15:30 ET

Nuvo Research announces director election results of its annual general meeting

MISSISSAUGA, ON, June 11, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI) a specialty pharmaceutical company with a diverse portfolio of...

May 29, 2014, 08:00 ET

Nuvo Research® announces U.S. FDA approval of third-party generic of PENNSAID 1.5%

MISSISSAUGA, ON, May 29, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of...

Apr 30, 2014, 17:00 ET

Nuvo Research® announces 2014 first quarter results

MISSISSAUGA, ON, April 30, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of...

Apr 23, 2014, 07:30 ET

Nuvo Research Announces Collaboration to Develop Topical Dermatology Products

MISSISSAUGA, ON, April 23, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of...

Apr 01, 2014, 07:30 ET

Nuvo Research® closes $3.1 million private placement

MISSISSAUGA, ON, April 1, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), (the "Company"), a specialty pharmaceutical company with a diverse...

Feb 20, 2014, 17:00 ET

Nuvo Research announces 2013 fourth quarter & year-end results

MISSISSAUGA, ON, Feb. 20, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of...

Feb 10, 2014, 08:00 ET

Nuvo Research Announces the U.S. Commercial Launch of PENNSAID® 2% by Mallinckrodt

MISSISSAUGA, ON, Feb. 10, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of...

Jan 17, 2014, 07:00 ET

Nuvo Research Announces FDA Approval of PENNSAID® 2%

- Mallinckrodt to Launch PENNSAID 2% in the U.S. in Q1 2014 - MISSISSAUGA, ON, Jan. 17, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a...

Dec 19, 2013, 07:30 ET

Nuvo Research® and NovaMedica sign agreement to market Pennsaid® in Russia

MISSISSAUGA, ON and MOSCOW, Dec. 19, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse...

Oct 30, 2013, 17:00 ET

Nuvo Research Announces 2013 Third Quarter Results

MISSISSAUGA, ON, Oct. 30, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio...

Oct 10, 2013, 07:30 ET

Nuvo Research® to Receive US$2.0 Million

Milestone Payment Related to Pliaglis Brazil Approval and Launch MISSISSAUGA, ON, Oct. 10, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a...

Sep 05, 2013, 07:30 ET

Nuvo Research® Announces Scientific Presentations at Annual Painweek 2013 Meeting

Data Evaluating Heated Lidocaine/Tetracaine Patch for the Treatment of Acute Musculoskeletal Pain to be Presented MISSISSAUGA, ON, Sept. 5,...

Aug 22, 2013, 07:30 ET

Nuvo Research® announces that FDA has accepted Pennsaid® 2% new drug application for review

MISSISSAUGA, ON, Aug. 22, 2013 /PRNewswire/ - Nuvo Research Inc. (Nuvo) (TSX:NRI), a specialty pharmaceutical company dedicated to building a...

Aug 21, 2013, 07:30 ET

Nuvo Research® announces lawsuit against Mallinckrodt

MISSISSAUGA, ON, Aug. 21, 2013 /PRNewswire/ - Nuvo Research Inc. (Nuvo) (TSX:NRI), a specialty pharmaceutical company dedicated to building a...

Aug 15, 2013, 07:30 ET

Nuvo announces Mallinckrodt submits PK study report in response to PENNSAID® 2% FDA complete response letter

MISSISSAUGA, ON, Aug. 15, 2013 /PRNewswire/ - Nuvo Research Inc. (Nuvo) (TSX:NRI), a specialty pharmaceutical company dedicated to building a...

Jul 31, 2013, 17:00 ET

Nuvo Research announces 2013 second quarter results

MISSISSAUGA, ON, July 31, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio...

Jul 23, 2013, 07:30 ET

Nuvo Research® announces update to Pennsaid® 2% Complete Response Letter

MISSISSAUGA, ON, July 23, 2013 /PRNewswire/ - Nuvo Research Inc. (Nuvo) (TSX: NRI), a specialty pharmaceutical company dedicated to building a...

Jul 10, 2013, 17:30 ET

Nuvo Research® and Paladin Labs announce completion of the loan arrangement

MISSISSAUGA, ON and MONTREAL, July 10, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building...